KDM1A and leukemia: MC3774 inhibited at the same time G9a and LSD1 (Ki values = 0.68 and 0.44 μM, respectively) and displayed micromolar/submicromolar anticancer activity against leukemia (THP-1 and MV4-11) and solid (breast MDA-MB-231 and rhabdomyosarcoma RD and RH30) cancer cells (Menna et al., 2022).